GlobeNewswire 2018-03-01 Symposium and Panel Discussion on Nymox's Fexapotide To Be Held at American Urological Association M...
GlobeNewswire 2018-02-05 Nymox Announces US NDA for Fexapotide for BPH
GlobeNewswire 2018-01-30 Fexapotide BPH Phase 3 Clinical Trial Results Published in World Journal of Urology
GlobeNewswire 2018-01-22 Nymox Reports 5-Year Results From Prospective Randomized Controlled Prostate Cancer Study of Fexapot...
GlobeNewswire 2017-11-27 Nymox Fexapotide Symposium and Panel Discussion at American Urological Association South Central Sec...
GlobeNewswire 2017-11-16 Nymox Fexapotide Symposium and Panel Discussion at American Urological Association North Central Sec...
GlobeNewswire 2017-11-10 Symposium and Panel Discussion on Nymox's Fexapotide To Be Held at American Urological Association N...
GlobeNewswire 2017-11-07 Nymox Reports on Symposium, Panel Discussion and Podium Presentation on Fexapotide at American Urolo...
GlobeNewswire 2017-10-26 Nymox Announces Two Data Presentations for Company's BPH Drug at New York American Urological Associ...
GlobeNewswire 2017-10-13 Nymox Reports on Symposium, Panel Discussion with Abstract on Fexapotide at American Urological Asso...
GlobeNewswire 2017-10-10 Nymox Reports on Symposium and Panel Discussion on Fexapotide at American Urological Association Nor...
GlobeNewswire 2017-09-25 Nymox Announces October 12 Symposium for Company's BPH Drug at American Urological Association Meeti...
GlobeNewswire 2017-09-14 Nymox Application Validated:
GlobeNewswire 2017-09-14 Nymox Announces New Symposium for Company's BPH Drug at American Urological Association Meeting Octo...
GlobeNewswire 2017-09-11 AUA Meeting in Florida September 16 Postponed Due to Hurricane
GlobeNewswire 2017-08-09 Nymox Announces Private Placements of $3 Million
GlobeNewswire 2017-08-07 Nymox Announces Symposium for Company's BPH Drug at American Urological Association Meeting in Septe...
GlobeNewswire 2017-05-31 Sexual Function Improves in First-Line Patients Given Fexapotide Treatment in Nymox U.S. BPH Long-Te...
GlobeNewswire 2017-05-10 NYMOX Files For Approval of First In Class Prostate Drug in Europe: Teleconference at 4:30 EDT
GlobeNewswire 2017-05-08 NYMOX Files For Approval of First In Class Prostate Drug in Europe: Company To Hold Teleconference W...
GlobeNewswire 2017-05-03 NYMOX Files For Marketing Approval For Fexapotide Triflutate in Europe
GlobeNewswire 2017-03-29 Nymox Provides Update on Fexapotide Development
GlobeNewswire 2016-11-29 Nymox Reports Additional Positive Results From Completed Fexapotide BPH Phase 3 Studies Showing Sign...
GlobeNewswire 2013-03-07 DISREGARD PREVIOUS RELEASE - RECORDATI : Board approves the 2012 accounts.
GlobeNewswire 2013-03-07 RECORDATI : Board approves the 2012 accounts.